# GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy

> **NCT01239251** · — · TERMINATED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** GlowCap device

## Key facts

- **NCT ID:** NCT01239251
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239251, "GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01239251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*